Marker Therapeutics Inc. (NASDAQ:MRKR) has a beta value of 1.29 and has seen 1,196,780 shares traded in the last trading session. The company, currently valued at $212.52 Million, closed the last trade at $2.56 per share which meant it lost -$0.12 on the day or -4.48% during that session. The MRKR stock price is -47.27% off its 52-week high price of $3.77 and 48.44% above the 52-week low of $1.32. If we look at the company’s 10-day average daily trading volume, we find that it stood at 2.37 Million shares traded. The 3-month trading volume is 3.32 Million shares.
The consensus among analysts is that Marker Therapeutics Inc. (MRKR) is a Buy stock at the moment, with a recommendation rating of 1.7. None of the analysts rate the stock as a Sell, while none rate it as Overweight. None out of 4 have rated it as a Hold, with 4 advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is -$0.14.
Marker Therapeutics Inc. (NASDAQ:MRKR) trade information
Despite being -4.48% in the red in last session, the stock has traded in the green over the last five days, with the highest price hit on Thursday, Apr 29 when the MRKR stock price touched $2.78-7 or saw a rise of 7.91%. Year-to-date, Marker Therapeutics Inc. shares have moved 76.55%, while the 5-day performance has seen it change 12.78%. Over the past 30 days, the shares of Marker Therapeutics Inc. (NASDAQ:MRKR) have changed 18.52%. Short interest in the company has seen 3.12 Million shares shorted with days to cover at 0.94.
Wall Street analysts have a consensus price target for the stock at $6.5, which means that the shares’ value could jump 153.91% from current levels. The projected low price target is $6 while the price target rests at a high of $8. In that case, then, we find that the current price level is +212.5% off the targeted high while a plunge would see the stock lose 134.38% from current levels.
Marker Therapeutics Inc. (MRKR) estimates and forecasts
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was +42% over the past 5 years. Earnings growth for 2021 is a modest -29.8%.
Marker Therapeutics Inc. (NASDAQ:MRKR)’s Major holders
Insiders own 19.75% of the company shares, while shares held by institutions stand at 27.26% with a share float percentage of 33.97%. Investors are also buoyed by the number of investors in a company, with Marker Therapeutics Inc. having a total of 90 institutions that hold shares in the company. The top two institutional holders are NEA Management Company, LLC with over 5Million shares worth more than $7.25 Million. As of December 30, 2020, NEA Management Company, LLC held 6.02% of shares outstanding.
The other major institutional holder is Blackrock Inc., with the holding of over 2.07 Million shares as of December 30, 2020. The firm’s total holdings are worth over $3Million and represent 2.49% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF. As of December 30, 2020, the former fund manager holds about 1.02% shares in the company for having 850493 shares of worth $1.23 Million while later fund manager owns 662.59 Thousand shares of worth $1.48 Million as of March 30, 2021, which makes it owner of about 0.8% of company’s outstanding stock.